Nestlé to cut jobs at Swiss food factory
The Swiss giant is investing SFr6.5m ($7.2m) to re-focus its Wangen facility.
Nestlé is set to cut 90 jobs at a facility in Switzerland as it “realigns” to producing two food brands.
The Swiss giant is investing SFr6.5m ($7.2m) to re-focus its Wangen facility, in the canton of Schwyz, which currently specialises in producing fresh dough.
Nestlé will now produce only two brands at the Swiss facility: Buitoni, an Italian pasta brand, and Leisi, which makes pastries and dough.
Nearly half of the total jobs at the Wangen factory will be cut in the new year as employees were informed of the changes mid-October, a Nestlé spokesperson told Just Food.
“We constantly review our activities and market requirements. The market conditions have changed and volumes abroad have decreased. We have therefore decided to concentrate on our core business with our own brands in the future,” the spokesperson said.
It is expected that the process will be finalised at the end of Q2.
Nestlé operates nine production sites in Switzerland and sells products under around 40 different brands for consumers and their pets.
Related news
Mondelēz investing $79M in Switzerland Toblerone factory
The snacks maker said the investment will help its goal…
Read more >Coop Switzerland saves food with sustainable private label
Coop Switzerland’s new sustainable private label, Nice-to-Save-Food, focuses on using…
Read more >Ideas from Hungarian youth are also welcome: Nestlé and UNESCO launch a joint global mentoring program for a sustainable future
Nestlé and UNESCO have announced a global partnership to support…
Read more >Related news
The “Promotion of the Year 2025” awards were presented on Promotions Day
The “Promotion of the Year 2025” competition, organized by Trade…
Read more >The outdoor season starts at Easter at the toy market
In families with young children, gift-giving remains a defining part…
Read more >Trump tariffs will also affect the pharmaceutical industry
Donald Trump’s new tariff plan aims to curb drug imports…
Read more >